Nordicus Partners Corp (NORD)
Nordicus Partners Corp. is a publicly traded common stock listing on OTC Markets under the symbol NORD. The company describes itself as a business accelerator and holding company focused on Nordic life sciences companies in the United States. Its activities include supporting medicine development with an emphasis on oral health, along with corporate finance-related services such as business and market development, growth planning, talent acquisition, partnership formation, capital raising, and assistance with company acquisitions and sales. Founded in 1993 and based in Beverly Hills, California, the company was previously known as EKIMAS Corporation before adopting its current name in May 2023.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-NORD
|
$3.59
|
63.9% Upside
|
Bargain
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
July 29, 2026
|
-11.8x
|
0.7x
|
—
|
47.025 M
|
44.77 M
|
0.1%
|
16.5%
|
-28.4
|
—
|
108.5%
|